US 2006/0134226 A1Published application

Compositions useful to treat ocular neovascular diseases and macular degeneration

OwnerTodd Leonardinventor

Life of this patent

Estimating the term…

Abstract

The present invention provides a composition that includes: (a) xanthophylls; (b) vitamin C; (c) vitamin E; (d) zinc; and (e) copper. The present invention also provides a method of treating macular degeneration in a human, inhibiting angiogenesis in a human, preventing impairment of the vision or for improving impaired vision of a human whose eye has drusen, and/or treating a disease associated with ocular neovascularitis in a human. The methods include administering to a human in need of such treatment an effective amount of the composition of the present invention.

Claims27

Dependent claims

A composition comprising:

(a) non-esterified lutein;
(b) zeaxanthin;
(c) vitamin C;
(d) vitamin E;
(e) zinc;
and
(f) copper.

4 more elements

Dependencies are inferred from the claim text.

Facts

Application: 11/280,960Filed 16 Nov 2005
Priority: 16 Nov 2004
Published: 22 Jun 2006
Term ends: Not estimatedThe source records don’t support an estimate.

Classification23 codes

A61K 45/06
Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00: mixtures of active ingredients without…
A61K 31/047
Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates: having two or more hydroxy groups, e.g. sorbitol
A61K 31/12
Medicinal preparations containing organic active ingredients: ketones
A61K 31/355
3,4-Dihydrobenzopyrans, e.g. chroman, catechin: tocopherols, e.g. vitamin E

Family

Application60/628,162Us provisional application · filed 16 Nov 2004
US 2006/0134226 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

patentgrepSearch patents

Back to results